Nivolumab plus ipilimumab for first-line treatment of advanced kidney cancer: Extended 4-year follow-up
Four-year follow up data are now available from the CheckMate [...]
Four-year follow up data are now available from the CheckMate [...]
A recent phase 1 trial showed that treatment with nivolumab [...]
A protein called γ-glutamyltransferase can predict survival in patients with [...]
In this phase 1b/2 study the researchers looked at a [...]
Tivozanib is a drug that blocks the blood supply to [...]
This recent retrospective study included 84 patients with metastatic renal [...]
Nivolumab alone and in combination with ipilimumab is used for the treatment of [...]
Further results from the ongoing CheckMate 214 phase III study [...]
Currently, it is difficult for clinicians to decide which patients [...]
Nivolumab was the first immunotherapy to be approved for the [...]